ACP Journal Club. Anti-TNFalpha therapy did not increase short- or medium-term risk for cancer in patients with rheumatoid arthritis

Ann Intern Med. 2010 May 18;152(10):JC5-13. doi: 10.7326/0003-4819-152-10-201005180-02013.
No abstract available

Publication types

  • Comment